Optinose to Present at the Jefferies Virtual Healthcare Conference

Rhea-AI Summary

Optinose (NASDAQ:OPTN), a pharmaceutical company specializing in ENT and allergy treatments, has announced that CEO Peter Miller will present a company overview at the Jefferies Virtual Healthcare Conference on June 3, 2021, at 3:30 p.m. ET. The public can access the presentation via the Investors page on the Optinose website. Additionally, a replay of the webcast will be available for 30 days post-event. For more details about Optinose and its services, visit www.optinose.com.

News Market Reaction – OPTN

-0.63%

-0.63% Session move

In the trading session that priced this news, OPTN declined 0.63%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

YARDLEY, Pa., June 01, 2021 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that Chief Executive Officer Peter Miller will present a company overview and business update at the Jefferies Virtual Healthcare Conference on June 3, 2021, at 3:30 p.m. ET.

To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website.

A replay of the webcast will be available for 30 days following the conclusion of the event.

About Optinose
Optinose is a global specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on Twitter and LinkedIn.

Optinose Investor Contact
Jonathan Neely
jonathan.neely@optinose.com 
267.521.0531

FAQ

When will Optinose present at the Jefferies Virtual Healthcare Conference?

Optinose will present on June 3, 2021, at 3:30 p.m. ET.

How can I listen to the Optinose presentation live?

You can listen to the presentation live by visiting the Investors page on the Optinose website.

Will a recording of the Optinose presentation be available?

Yes, a replay of the webcast will be available for 30 days after the event.

What is the focus of Optinose as a pharmaceutical company?

Optinose specializes in serving patients treated by ear, nose, and throat (ENT) and allergy specialists.

What is the stock symbol for Optinose?

The stock symbol for Optinose is OPTN.